Key result
Depression shows no link to all-cause or cardiovascular mortality in long-term haemodialysis patients.
Why the study?
Does depression increase the risk of all-cause and cardiovascular mortality in adults treated with long-term haemodialysis?
Cohort (n=2,278)
Yes
Does depression increase the risk of all-cause and cardiovascular mortality in adults treated with long-term haemodialysis?
In adults on long-term hemodialysis, moderate depression (BDI ≥20) is associated with increased all-cause mortality, but neither mild nor moderate depression is significantly associated with cardiovascular mortality.
Answers are grounded in this paper and cite their sources.
Depression screening may not flag CV mortality risk in hemodialysis; leaves open whether moderate symptoms affect cardiovascular outcomes.
Background: Depression and early death are both common in adults with Stage 5 chronic kidney disease. Studies have shown an association between depression and total mortality, but the association between depression and cardiovascular death is less certain. Methods: We conducted a prospective multinational cohort study involving adults who were treated with long-term haemodialysis within a single dialysis network between April and November 2010. Depression was considered present when patients reported a Beck Depression Inventory (BDI) II score ≥14 at baseline. Sensitivity analyses considered a BDI II score ≥20 to identify moderate depression. Multivariable Cox proportional hazards regression was used to assess adjusted hazards for all-cause and cardiovascular mortality at 12 months. Results: Three thousand and eighty-six participants in the network received the BDI II questionnaire, and 2278 (73%) provided complete responses to the survey questions. Among these, 1047 (46%) reported depression. During a mean follow-up of 11 (standard deviation: 2.5) months (2096 person-years), we recorded 175 deaths, of which 66 were attributable to cardiovascular causes. Depression (BDI score ≥14) was not associated with all-cause mortality [adjusted hazard ratio: 1.26 (95% confidence interval: 0.93–1.71)] or cardiovascular mortality [0.82 (0.50–1.34)]. When a higher BDI score (BDI score ≥20) was used to identify moderate depression, depression was associated with total mortality [1.40 (1.02–1.93)] but not cardiovascular mortality [1.05 (0.63–1.77)]. Conclusions: The association between depression and cardiovascular mortality in adults with kidney failure treated with haemodialysis is uncertain. Depression is a heterogeneous disorder and may only be a risk factor for premature death when at least of moderate severity.
No takes yet. Share an insight, caveat, or question.
Saglimbene et al. (2016) conducted a cohort in Stage 5 chronic kidney disease on long-term haemodialysis (n=2,278). Depression (BDI II score ≥14) vs. No depression (BDI II score <14) was evaluated on All-cause mortality at 12 months (HR 1.26, 95% CI 0.93-1.71). Depression (BDI score ≥14) was not associated with all-cause mortality or cardiovascular mortality in adults on long-term haemodialysis.
Synapse has enriched 10 related papers. Consider them for comparative context: